Daniel Tasse Email & Phone Number
CEO and Directeur General @ DBV Technologies
5 free lookup(s).
No credit card required.
Daniel Tasse Location
- New York, NY, US
Daniel Tasse Work
- 2018 - now CEO and Directeur General @
- 2015 - now Indivior (INDV); Regenxbio (RGNX) @ Non Executive Director
- 2015 - 2019 Non Executive Director @ HLS Therapeutics Inc. Bellerophon Therapeutics
- 2016 - 2018 CEO and Chairman @
- 2008 - 2015 Chairman and CEO @
- 2004 - 2008 General Manager - Pharmaceutical and Technologies Business Unit @
- 2001 - 2004 Vice President and Managing Director - Australasia @
Daniel Tasse Education
- Université de Montréal
Bachelor of Science (B.Sc.) (Biochemistry, Mathematics)
1978 - 1982
Daniel Tasse Skills
- Highly accomplished Executive and Director in Health Care
- Succesfully built businesses in Drug, Devices and HC Delivery
- Strong Leadership abilities and sound business judgment
- Critical Thinker with collegial approach - seeks original solutions to problems
- Consistently built significant value and returns for shareholders
- Experienced in best practice governance for Public and Private Cos
- Pharmaceutical Industry
- Pharmaceutical Sales
- Biotechnology
- Medical Devices
- Strategic Planning
- Cross-functional Team Leadership
- Product Launch
- Clinical Trials
- Clinical Development
- Marketing
- Sales Effectiveness
- Oncology
- Drug Development
- Critical Care
- Cardiology
- Strategy
- Leadership
- Pharmaceutics
- Coaching
- FDA
- Healthcare
- Management
- Regulatory Affairs
- Succesfully Built
- Banking
- Cross Functional Team
- Experienced In Best
- Succesfully Built Businesses In Drug
- Consistently Built
- Critical Thinker With Collegial Approach
- Devices And Hc Delivery
- Microsoft Office
- Strong Leadership
- Cross Functional Team Leadership
- Seeks Original Solutions To Problems
- Project Management
- Highly Accomplished
- Business Development
- Team Building
- Microsoft Excel
Daniel Tasse Summary
- Daniel Tasse, based in New York, NY, US, is currently a CEO and Directeur General at DBV Technologies. Daniel Tasse brings experience from previous roles at Non Executive Director, HLS Therapeutics Inc. Bellerophon Therapeutics, Alcresta Therapeutics and IKARIA. Daniel Tasse holds a 1978 - 1982 Bachelor of Science (B.Sc.) in Biochemistry, Mathematics @ Université de Montréal. With a robust skill set that includes Highly accomplished Executive and Director in Health Care, Succesfully built businesses in Drug, Devices and HC Delivery, Strong Leadership abilities and sound business judgment, Critical Thinker with collegial approach - seeks original solutions to problems, Consistently built significant value and returns for shareholders and more. Daniel Tasse has 3 emails and 3 mobile phone numbers on RocketReach.
5 free lookup(s).
No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Looking for a different Daniel Tasse?
Find contact details for 700 million professionals.
Others Named Daniel Tasse
Daniel Tasse
CEO and Directeur General
New York, NY, US
Top DBV Technologies Employees
Daniel Tasse
CEO and Directeur General
New York, NY, US
Karen Disanto
Vice President, Human Resources (US and Australia)
Parsippany-Troy Hills, NJ, US
Tee Bahnson
Vice President
Seattle, WA, US
Anne Pollak
Vice President, US Commercial Strategy
New Providence, NJ, US
Jessica Bruno-Raiz
Vice President Clinical Operations
Morristown, NJ, US
Todd Green
Vice President Clinical Development and Medical Affairs
Pittsburgh, PA, US
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups. 
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension. 
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API. 
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co